Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
3.
Int J Gynaecol Obstet ; 138 Suppl 1: 4-6, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28691327

ABSTRACT

The outlook for elimination of the scourge of cervical cancer is bright, because we now have the tools to achieve this goal. In recent years human papillomavirus (HPV) vaccination in high-income countries has resulted in dramatic decreases in HPV infection and associated cervical disease. If all countries with a substantial burden of disease introduce the vaccine nationally, we can protect the vast majority of women and girls most at risk. For women who are beyond the vaccination target age, progress has been made in screening and treatment for cervical precancer, but we must accelerate this momentum to reduce incidence and mortality worldwide to the very low rates found in wealthier countries. Human and financial resources must be increased and directed to programs that follow best practices and reach all women, including the marginalized or disadvantaged. Seven key actions are recommended. Now is the time for action at national, regional, and global levels.


Subject(s)
Mass Vaccination , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/supply & distribution , Uterine Cervical Neoplasms/prevention & control , Female , Global Health , Health Plan Implementation , Humans , Women's Health
4.
J Acquir Immune Defic Syndr ; 75 Suppl 1: S1, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28398990

Subject(s)
HIV Infections , Humans
6.
J Int AIDS Soc ; 19(4 Suppl 3): 21196, 2016.
Article in English | MEDLINE | ID: mdl-27435720
9.
Bull World Health Organ ; 94(6): 408, 2016 Jun 01.
Article in English | MEDLINE | ID: mdl-27274589
11.
Lancet ; 387(10034): 2176-7, 2016 May 28.
Article in English | MEDLINE | ID: mdl-27145704
12.
Bull. W.H.O. (Print) ; 94(6): 408-408, 2016-6-01.
Article in English | WHO IRIS | ID: who-271924
14.
17.
Lancet ; 385(9964): 287-301, 2015 Jan 17.
Article in English | MEDLINE | ID: mdl-25059950

ABSTRACT

The women, men, and transgender people who sell sex globally have disproportionate risks and burdens of HIV in countries of low, middle, and high income, and in concentrated and generalised epidemic contexts. The greatest HIV burdens continue to be in African female sex workers. Worldwide, sex workers still face reduced access to needed HIV prevention, treatment, and care services. Legal environments, policies, police practices, absence of funding for research and HIV programmes, human rights violations, and stigma and discrimination continue to challenge sex workers' abilities to protect themselves, their families, and their sexual partners from HIV. These realities must change to realise the benefits of advances in HIV prevention and treatment and to achieve global control of the HIV pandemic. Effective combination prevention and treatment approaches are feasible, can be tailored for cultural competence, can be cost-saving, and can help to address the unmet needs of sex workers and their communities in ways that uphold their human rights. To address HIV in sex workers will need sustained community engagement and empowerment, continued research, political will, structural and policy reform, and innovative programmes. But such actions can and must be achieved for sex worker communities everywhere.


Subject(s)
HIV Infections/prevention & control , Sex Workers/statistics & numerical data , Anti-HIV Agents/therapeutic use , Delivery of Health Care , Female , Global Health , HIV Infections/drug therapy , HIV Infections/epidemiology , Health Services Accessibility , Human Rights/legislation & jurisprudence , Humans , Male , Molecular Epidemiology , Transgender Persons/statistics & numerical data , Viral Load
18.
Bull. W.H.O. (Print) ; 93(1): 3-3, 2015-1-01.
Article in English | WHO IRIS | ID: who-271639
SELECTION OF CITATIONS
SEARCH DETAIL
...